A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancer.
De Vries
E G
EG
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
Nanninga
A G
AG
Greidanus
J
J
Oremus
E T
ET
Verschueren
R C
RC
Mulder
N H
NH
Sleijfer
D T
DT
Willemse
P H
PH
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy*
D015251:Epirubicin